Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03393936
Recruitment Status : Active, not recruiting
First Posted : January 9, 2018
Last Update Posted : October 21, 2021
Shanghai Public Health Clinical Center
Information provided by (Responsible Party):
Shanghai PerHum Therapeutics Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 30, 2022
Estimated Study Completion Date : June 30, 2023